No Data
Retail Investors Invested in Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) Copped the Brunt of Last Week's CN¥474m Market Cap Decline
Zhejiang Shouxiangu Pharmaceutical Subsidiary Gets 350-Million-Yuan Construction Contract
Zhejiang Shouxiangu Pharmaceutical (603896.SH): Subsidiary intends to sign the Zhejiang Shouxiangu Digital Center construction contract.
On September 29, Gleonhui announced that in September 2024, Shouxiangu Pharmaceutical (603896.SH) invited Hangzhou Tianhe Construction Group Co., Ltd., Zhejiang Yaohua Construction Group Co., Ltd., Hangzhou Zhongmin Construction Engineering Co., Ltd., and other companies to negotiate the total construction contract for Shouxiangu Smart Center building project for commercial and business use of Hangzhengch储 [2024] No.18. After multiple evaluations, Hangzhou Zhongmin Construction Engineering Co., Ltd. (referred to as "Hangzhou Zhongmin") was selected as the successful bidder. The company held the 24th meeting of the fourth board of directors on September 29, 2024 to review and approve the "Shouxiangu Pharmaceutical on the whole...
Zhejiang Shouxiangu Pharmaceutical's (SHSE:603896) Earnings Trajectory Could Turn Positive as the Stock Surges 10% This Past Week
Zhejiang Shouxiangu Pharmaceutical (603896.SH): The product 'Shouxiang Tang brand broken ganoderma spore powder' has completed the filing of domestic health food.
On September 19, Gelonhui announced that zhejiang shouxiangu pharmaceutical (603896.SH), the company's wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd.'s "Shouxian Tang brand broken reishi spore powder" product has completed the filing of domestic health food and obtained the domestic health food filing certificate issued by the Zhejiang Provincial Market Supervision and Administration Bureau.
Traditional Chinese medicine health products face difficulties in transitioning online. Shouxiangu Pharmaceuticals: Striving to have top anchors promote products during the singles' day sales. | Earnings conference in focus.
①The demand for traditional Chinese medicine health products has not improved; ②Zhejiang Shouxiangu pharmaceutical is promoting singles' day sales through live streaming hosts; ③Multiple measures are taken to maintain product price stability; ④Online transformation still faces certain challenges.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Prospects Need A Boost To Lift SharesNo Data
No Data
